Minapharm profit skyrockets
Minapharm Pharmaceuticals (Minapharm) reported a 184% Year on Year increase in its consolidated net profit in the first nine months
Arab Finance - 29 Nov 2020
Minapharm Pharmaceuticals S.A.E. (MIPH.CA)
Also known as: MINAPHARM
86.50 EGP 0.000.00%
MINAPHARM Stock Price & Performance
Recommendation
-
Div Yield
6.243%
P/E (Last 12 Month)
3.92
Upside
-
Target Price (Mean)
-
Open
84.21 EGP
Previous Close
86.50 EGP
Turnover
239.59K EGP
EPS
22.068 EGP
Volume
2,772
Transactions
14
Market Cap
1.06B EGP
IPO Date
11-Jan-2004
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Minapharm Pharmaceuticals S.A.E.
Business Summary
Production of licensed and generic pharmaceuticals, vaccines, veterinary products, drug delivery systems, cosmetics and skin care supplies.
Country of Incorporation
Ownership Type
Established In
1986
Primary Sector
Number of Employees
-
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| MIPH.CASE | Ordinary | EGP | Egypt SE | MIPH |
Contact details
Primary address
Building: Building 6CStreet: El Bardissi Street, 2T Taksim Asmaa Fahmy Street
Floor: 2nd Floor
Country: Egypt
City: Heliopolis
CONTACT
- Tel: +20 2-2414-3170
- Tel: +20 2-2414-3175
- Fax: +20 2-2414-3179
- Email: mailbox@minapharm.com
- www.minapharm.com
Related links
www.probiogen.deRegion
CairoOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Dr Wafiq Saad Al Bardissi
Managing Director
Mr Albert Sami Barsoum
Investor Relations Manager
Board Members
Dr Wafiq Saad Al Bardissi
Chairman
Dr Amro Sobhi Mohammed Sobhy Hamza El-Shabrawishy
Vice Chairman
Dr Anwar Nasser Mikhael
Director
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Zawya Coverage
Dnata opens state-of-the-art cargo complex at Manchester Airport
UAE's Mubadala Petroleum signs deal to explore oil, gas in Red Sea
Abu Dhabi Fund for Development completes $31.94mln energy projects in partner countries
Flydubai to start double daily flights to Qatar
CEO of Saudi's Basic Chemical Industries resigns
Thursday Outlook: Asian stocks at record highs; dollar on back foot
Oil slips; gold off two-week high on profit booking
Stock Market Data
Powered By Knowledge Direct